|Articles|November 1, 2002
Changing of guard: CIBA Vision successor takes reins as CEO retires
Atlanta-Glen Bradley will retire as chief executive officer of CIBA Vision in early 2003 after more than 30 years of service with affiliated Novartis Corp. companies.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
New optoretinography technique allows direct measurement of rod function in vivo
2
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
3
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
4
FDA grants breakthrough therapy designation to Oculis’ privosegtor for optic neuritis
5








































